~~<i id='7B6F97568F'><strike id='7B6F97568F'><tt id='7B6F97568F'><pre id='7B6F97568F'></pre></tt></strike></i>~~

Home» Wikipedia» explore

explore

author：Wikipedia 2025-10-06 13:25:32 Page View：332

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation
Next article： Novavax promises a turnaround & Lilly roils the obesity market

explore

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

1:15FileimageoftheTitansubmersiblepriortocommencediving.OceanGateThesubmersiblethatwasreportedmissin

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

STAT Readout Newsletter: Today's biggest biotech updates

Photoillustration:STATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiot